Results 81 to 90 of about 1,320 (101)

Health care utilization and cost implications of Chile's 2024 nirsevimab strategy for RSV prevention: a counterfactual analysis. [PDF]

Lancet Reg Health Am
Sauré D, Zgheib A, Torres JP, Goic M, Thraves C, Pacheco J, Burgos J, Del Solar F, Neira I, O'Ryan M, Basso LJ.   +10 more
europepmc   +1 more source

[Analysis of the surveillance system for adverse events following Immunization (AEFI) related to COVID-19 vaccines in Colombia, 2021-2023Análise do sistema de vigilância de ESAVI por vacinas contra a COVID-19 na Colômbia, 2021-2023]. [PDF]

Rev Panam Salud Publica
Saza-Londoño W, Pinzón-Fajardo DY, Urrea-Duque MV, Pinzón-Niño EL, Sánchez-León EM, Urieles-Sierra KI, Pinto-Díaz CA, Molina-León HF.   +7 more
europepmc   +1 more source

[Environmental medicine and AI, migration, and emerging and reemerging diseases in Mexico]. [PDF]

Rev Med Inst Mex Seguro Soc
Rivera-Silva G, Moreno-Treviño MG, Garza-Martínez R.   +2 more
europepmc   +1 more source

[Lessons learned in the implementation of measles and rubella vaccination campaigns in the AmericasLições aprendidas com a implementação de campanhas de vacinação contra sarampo e rubéola na Região das Américas]. [PDF]

Rev Panam Salud Publica
Durón R, Pastor D, Whittembury Á, Rocha Queiroz Lemos D.   +3 more
europepmc   +1 more source

[Communicating Vaccine-related Events: Experiences with ESAVIComunicação de eventos relacionados a vacinas: experiências com ESAVI]. [PDF]

Rev Panam Salud Publica
López Morales EC, Cerón Coral C.
europepmc   +1 more source

[Strategies and Barriers to the Implementation of Continuing Education in Sentinel Hospitals for the Surveillance of COVID-19 Vaccine Safety in Honduras, 2022-2023Formação continuada: estratégias e barreiras de implementação em hospitais sentinela para a vigilância da segurança das vacinas contra a COVID-19 em Honduras, 2022-2023]. [PDF]

Rev Panam Salud Publica
Zúniga C, Cárcamo E, Romualdo-Tello NM, Solarte Agredo IN, Álvarez V, Moya I, Galeas J, Burgos N, Raudales A, Zapata L, Soto S, Gamero M.   +11 more
europepmc   +1 more source

[Events attributable to Vaxzevria vaccine in pregnant women from a first-level hospital in Puebla]. [PDF]

Rev Med Inst Mex Seguro Soc
Huerta-Rojas JA, Bravo-de la Rosa G, Texis-Ramírez J, Reyes-Tobón IT.   +3 more
europepmc   +1 more source

[Nirsevimab effectiveness against hospital admission for respiratory syncytial virus bronchiolitis in infants]. [PDF]

Rev Esp Quimioter
Rodríguez-Fernández R, González-Martínez F, Ojeda Velázquez I, Rodríguez Díaz M, Capozzi Bucciol MV, González-Sánchez MI, Pérez-Moreno J, Toledo Del Castillo B.   +7 more
europepmc   +1 more source

Geopharmacosurveillance of reporting rates of events supposedly attributable to vaccination or immunization against COVID-19. [PDF]

Rev Lat Am Enfermagem
Barbosa TCP, Nascimento GLMD, Arroyo LH, Arcêncio RA, Oliveira VC, Guimarães EAA.   +5 more
europepmc   +1 more source